Ormutivimab
Modify Date: 2025-08-25 15:18:46
Ormutivimab structure
|
Common Name | Ormutivimab | ||
|---|---|---|---|---|
| CAS Number | 2449086-91-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OrmutivimabOrmutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model[1][2]. |
| Name | Ormutivimab |
|---|
| Description | Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Ormutivimab (20 IU/kg；肌肉注射；单剂量) 保护比格犬免受 RABV BD06 的致命攻击[1]。 Ormutivimab (20 IU/kg、100 IU/kg；肌注；单剂量) 保护受攻击的 Kunming 小鼠免受各种狂犬病病毒的侵害[1]。 Animal Model: Balb/c mice challenge model with rabies virus[1] Dosage: 20 IU/kg, 100 IU/kg Administration: Intramuscular injection; single dose after 4 hr after infection Result: Protected mice from rabies CVS-24 and GZ-1 isolates at a comparable rate (90%) to that of HRIG, human antirabies immune globulin. |
| References |
| No Any Chemical & Physical Properties |